KUALA LUMPUR (Aug 27): As of yesterday (Aug 26), 60.2% of Malaysia's adult population had been fully vaccinated, while 80.9% had received at least one dose of the vaccine, according to the latest updates on Twitter today by the country’s Special Committee for Ensuring Access to Covid-19 Vaccine Supply (JKJAV).

In terms of the total population, 58% or 18.95 million people had received at least one dose of the vaccine, including 43.2% of the population or 14.1 million recipients who were fully inoculated.

As of yesterday, 33.04 million Covid-19 vaccine doses had been administered. 

Data cited from the Covid-19 Immunisation Task Force (CITF) showed that Malaysia’s daily administered Covid-19 vaccine doses slipped to 408,295 yesterday from 423,380 a day earlier. 

Of the 408,295 vaccine doses administered, 155,669 were first jabs and 252,626 were second shots.

Based on the government’s target of having 80% of the population fully vaccinated against Covid-19 to achieve herd immunity, the country will need to have about 26 million people completing their two-dose vaccination. 

Yesterday, Malaysia reported 24,599 new Covid-19 cases, the highest number in the nation since the pandemic started, pushing the number of active cases up to 265,841. 

The latest infections were discovered from testing 160,196 individuals across the country in the 24 hours as of noon yesterday, indicating a positivity rate of 15.36%. 

According to a statement by Health director-general Tan Sri Dr Noor Hisham Abdullah, the nation also reported its highest daily number of deaths at 393 yesterday, including 100 brought-in-dead cases. 

This put the country's total number of Covid-19 fatalities at 15,211. 

Get the latest news @ www.EdgeProp.my

Subscribe to our Telegram channel for the latest stories and updates 

Click here for more property stories

SHARE
RELATED POSTS
  1. Sinovac vaccine efficacy drops to 28% in three to five months — report
  2. Solution Group obtains MoH approval for private sales of CanSino vaccine
  3. MoH: Sinovac, AstraZeneca vaccines get conditional approval for use as booster shots